Project Grant 90CU0031

Federal Cooperative Agreement Award Summary The National Institute on Drug Abuse (NIDA) awarded a Cooperative Agreement valued at $1,939,646 to Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) for a two-phase clinical research study investigating semaglutide as a treatment for methamphetamine use disorder (MEUD). Under the Drug Use and Addiction Research Programs (CFDA 93.279), the award supports research activities conducted in San Francisco, California, from...

Grant Award Summary The Massachusetts State Police Department received a $2.0 million Project Grant from the Community Oriented Policing Services (COPS) Office under the COPS Anti-Methamphetamine Program (CFDA 16.072), effective October 1, 2025, through September 30, 2028. This three-year award funds investigative operations and task force activities targeting illicit methamphetamine manufacturing, distribution, and precursor chemical diversion schemes throughout Massachusetts. The grant...

Federal Grant Award Summary The National Institute on Drug Abuse awarded Oklahoma Medical Research Foundation (OMRF) a Project Grant of $648,389 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning February 15, 2026, with completion targeted for November 30, 2030. This award supports basic neuroscience research investigating cell type-specific neurotensin signaling in methamphetamine use disorder. The research combines intravenous methamphetamine self-administration studies...

Federal Project Grant Award Summary The University of Utah's Office of Sponsored Projects received a $462,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2026 through April 30, 2031. This award supports research to illuminate neuropeptide modulation of methamphetamine withdrawal through development of novel photochemical tools. The research will engineer a modular library of photolabile...

Federal Project Grant Award Summary The Michigan State Police received a $1,415,225 Project Grant from the Department of Justice's Community Oriented Policing Services (COPS) Anti-Methamphetamine Program (CAMP), CFDA 16.072, awarded on October 1, 2025, with a completion date of September 30, 2028. This three-year award funds investigative operations targeting illicit methamphetamine manufacturing, distribution, and precursor chemical diversion schemes throughout Michigan. The grant supports...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, San Diego a $4.95 million project grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Brain-Focused Research on Antiretrovirals and Methamphetamine (BRAIN-FRAME) initiative. The five-year award, which commenced May 15, 2026, and extends through March 31, 2031, supports a multidisciplinary research program investigating the intersection of methamphetamine use...

Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $668,423 Project Grant on April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports an integrated research initiative examining MECOM (MDS1 and EVI1 Complex Locus Protein) as a molecular regulator of microglial dysfunction in people with HIV who use methamphetamine. The research deliverables include comprehensive multi-omics analyses combining...

The Guam Police Department received a $1.24 million Project Grant from the Community Oriented Policing Services (COPS) Anti-Methamphetamine Program (CAMP), CFDA 16.072, awarded October 1, 2025, with a completion date of September 30, 2028. This three-year award supports investigative operations targeting illicit methamphetamine manufacturing, distribution, and precursor chemical diversion activities throughout Guam. The funding enables the state law enforcement agency to enhance its...

Federal Project Grant Award Summary The Community Oriented Policing Services (COPS) Anti-Methamphetamine Program (CAMP) awarded $1.64 million to the Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OK ST Bureau Narcotics) on October 1, 2025, for a three-year performance period through September 30, 2028. Under CFDA 16.072, this competitive grant funds investigative operations and task force activities targeting illicit methamphetamine manufacturing, distribution, and precursor...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Miami a $516,914 Project Grant effective May 1, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative investigates the molecular mechanisms underlying HIV (human immunodeficiency virus) infection and latency in brain pericytes, with particular focus on how methamphetamine (METH) use influences the formation and maintenance of...